Evidence map›Paper›PMID 28878001›Full record

ArticleThe Journal of experimental medicine2017

NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome.

Kyoko Hayakawa, Anthony M Formica, Yan Zhou, Daiju Ichikawa, Masanao Asano, Yue-Sheng Li, Susan A Shinton, Joni Brill-Dashoff, Gabriel Núñez, Richard R Hardy

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kyoko HayakawaFox Chase Cancer Center, Philadelphia, PA kyoko.hayakawa@fccc.edu.ORCID http://orcid.org/0000-0003-3157-5897
Anthony M FormicaFox Chase Cancer Center, Philadelphia, PA.ORCID http://orcid.org/0000-0002-9209-0335
Yan ZhouFox Chase Cancer Center, Philadelphia, PA.ORCID http://orcid.org/0000-0002-8698-0040
Daiju IchikawaFox Chase Cancer Center, Philadelphia, PA.ORCID http://orcid.org/0000-0002-5940-2720
Masanao AsanoFox Chase Cancer Center, Philadelphia, PA.
Yue-Sheng LiFox Chase Cancer Center, Philadelphia, PA.
Susan A ShintonFox Chase Cancer Center, Philadelphia, PA.ORCID http://orcid.org/0000-0003-2649-1904
Joni Brill-DashoffFox Chase Cancer Center, Philadelphia, PA.ORCID http://orcid.org/0000-0002-8596-5877
Gabriel NúñezDepartment of Pathology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI.
Richard R HardyFox Chase Cancer Center, Philadelphia, PA.ORCID http://orcid.org/0000-0002-9809-5583
Fox Chase Cancer Center · USUniversity of Michigan · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
DNA Sequencing CoreZICHL006229 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LI, YUE-SHENG · 2017 to 2025
$35.4M
LY-1 B CELLS--LINEAGE DETERMINATION/ANTIBODY REPERTOIRER01AI026782 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI HARDY, RICHARD R · 1990 to 2011
$5.5M
Nod2: A Susceptibility Gene for Crohn's DiseaseR01DK061707 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NUNEZ, GABRIEL · 2002 to 2017
$4.7M
Development and Function of Natural Autoreactive B CellsR01AI049335 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI HAYAKAWA, KYOKO · 2002 to 2012
$4.1M
Mechanisms regulating the B lymphopoiesis fetal/adult switchR01AI113320 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI HAYAKAWA, KYOKO · 2015 to 2019
$2.0M
Generation and characterization of human B1 B cells induced by Lin28b reprogramming of adult hematopoietic progenitorsR21AI117429 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI HAYAKAWA, KYOKO · 2015 to 2016
$491k
Ly-1 B Cells: Developmental Origins and V Gene BiasesR56AI026782 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI HARDY, RICHARD R · 2013 to 2013
$313k
NCI NIH HHS P30 CA006927NIAID NIH HHS R01 AI026782NIAID NIH HHS R01 AI049335NIAID NIH HHS R01 AI113320NIAID NIH HHS R21 AI117429NIAID NIH HHS R56 AI026782NIDDK NIH HHS R01 DK061707
6 · The paper itself

Abstract

Although B cell development requires expression of the B cell antigen receptor (BCR), it remains unclear whether engagement of self-antigen provides a positive impact for most B cells. Here, we show that BCR engagement by self-ligand during development in vivo results in up-regulation of the Nod-like receptor member Nod1, which recognizes the products of intestinal commensal bacteria. In anti-thymocyte/Thy-1 autoreactive BCR knock-in mice lacking self-Thy-1 ligand, immunoglobulin light chain editing occurred, generating B cells with up-regulated Nod1, including follicular and marginal zone B cells with natural autoreactivity. This BCR editing with increased Nod1 resulted in preferential survival. In normal adult mice, most mature B cells are enriched for Nod1 up-regulated cells, and signaling through Nod1 promotes competitive survival of mature B cells. These findings demonstrate a role for microbial products in promoting survival of mature B cells through up-regulated Nod1, providing a positive effect of BCR engagement on development of most B cells.

Indexed as

AgingAnimalsB-LymphocytesGene Knock-In TechniquesMiceMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicNLR ProteinsNod1 Signaling Adaptor ProteinReceptors, Antigen, B-CellSignal TransductionUp-RegulationNLR ProteinsNod1 protein, mouseNod1 Signaling Adaptor ProteinReceptors, Antigen, B-Cell

Identifiers

PMID28878001
PMCPMC5626402
OpenAlexW2750642295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.